These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31888545)

  • 21. Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma.
    Furukawa Y; Kikuchi J
    Int J Hematol; 2016 Sep; 104(3):281-92. PubMed ID: 27411688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mechanisms of drug resistance via the interaction of myeloma cells with stromal cells].
    Kikuchi J; Furukawa Y
    Nihon Rinsho; 2015 Jan; 73(1):57-61. PubMed ID: 25626305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of beta(1)-integrin in K562 chronic myelogenous leukemia cell line.
    Guo-Bao W; Xiao-Qin C; Qi-Rong G; Jie L; Gui-Nan L; Yue L
    Leuk Lymphoma; 2010 Jun; 51(6):1090-7. PubMed ID: 20470221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The integrin beta1 subunit transmembrane domain regulates phosphatidylinositol 3-kinase-dependent tyrosine phosphorylation of Crk-associated substrate.
    Armulik A; Velling T; Johansson S
    Mol Biol Cell; 2004 Jun; 15(6):2558-67. PubMed ID: 15034138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
    Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
    Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EphA4 promotes cell proliferation and cell adhesion-mediated drug resistance via the AKT pathway in multiple myeloma.
    Ding L; Shen Y; Ni J; Ou Y; Ou Y; Liu H
    Tumour Biol; 2017 Mar; 39(3):1010428317694298. PubMed ID: 28351297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
    Nefedova Y; Landowski TH; Dalton WS
    Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3.
    Lin L; Yan F; Zhao D; Lv M; Liang X; Dai H; Qin X; Zhang Y; Hao J; Sun X; Yin Y; Huang X; Zhang J; Lu J; Ge Q
    Oncotarget; 2016 Mar; 7(9):9844-58. PubMed ID: 26848618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor.
    Holt RU; Baykov V; Rø TB; Brabrand S; Waage A; Sundan A; Børset M
    Haematologica; 2005 Apr; 90(4):479-88. PubMed ID: 15820943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia.
    Yanamandra N; Colaco NM; Parquet NA; Buzzeo RW; Boulware D; Wright G; Perez LE; Dalton WS; Beaupre DM
    Clin Cancer Res; 2006 Jan; 12(2):591-9. PubMed ID: 16428505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells.
    Van Riet I; De Waele M; Remels L; Lacor P; Schots R; Van Camp B
    Br J Haematol; 1991 Nov; 79(3):421-7. PubMed ID: 1721526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells.
    Shen Y; Sun Y; Zhang L; Liu H
    Tumour Biol; 2017 Jun; 39(6):1010428317703941. PubMed ID: 28653881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway.
    Tian T; Li CL; Fu X; Wang SH; Lu J; Guo H; Yao Y; Nan KJ; Yang YJ
    J Int Med Res; 2018 Apr; 46(4):1311-1325. PubMed ID: 29332411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a cell adhesion-based prognostic model for multiple myeloma: Insights into chemotherapy response and potential reversal of adhesion effects.
    Hu Q; Wang M; Wang J; Tao Y; Niu T
    Oncol Res; 2024; 32(4):753-768. PubMed ID: 38560563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma.
    Faid L; Van Riet I; De Waele M; Facon T; Schots R; Lacor P; Van Camp B
    Eur J Haematol; 1996 Nov; 57(5):349-58. PubMed ID: 9003475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RBQ3 participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
    Liu H; Ding L; Shen Y; Zhong F; Wang Q; Xu X
    Int J Biol Macromol; 2016 Oct; 91():115-22. PubMed ID: 27189701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas.
    Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Wang Y; Cheng C
    Leuk Res; 2016 Nov; 50():104-111. PubMed ID: 27701018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells in vitro.
    Cordes N; Blaese MA; Plasswilm L; Rodemann HP; Van Beuningen D
    Int J Radiat Biol; 2003 Sep; 79(9):709-20. PubMed ID: 14703944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells.
    Hazlehurst LA; Argilagos RF; Dalton WS
    Br J Haematol; 2007 Jan; 136(2):269-75. PubMed ID: 17233818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.